Brachial Plexus and Peripheral Nerve Surgery Unit, Neuro Spinal Hospital, Dubai, United Arab Emirates.
Neurol India. 2019 Jan-Feb;67(Supplement):S38-S44. doi: 10.4103/0028-3886.250697.
Neurofibromatosis 1 (NF1) is associated with peripheral nerve tumors (PNTs) in about 30% of cases. In comparison with sporadic forms, NF1 PNTs present some peculiarities: (1) A large prevalence of neurofibromas; (2) the presence of pathognomonic tumoral forms (plexiform neurofibromas); and, (3) a higher incidence (lifetime risk is equal to 8-13%) and an earlier age of onset (2-3 versus 3-6 decades) of malignant peripheral nerve sheath tumors (MPNSTs). For fear of inducing neurological complications, surgical removal of PNTs is generally recommended for symptomatic tumors only. Yet, it can be safely performed by surgeons with expertise in the field. A valid preventive strategy is also essential. Based on the evidence that in NF1, one-third of MPNSTs are consequent to malignant transformation of pre-existing benign tumors, a more aggressive surgical attitude should be advocated.
神经纤维瘤病 1 型(NF1)与大约 30%的病例中的周围神经肿瘤(PNTs)相关。与散发性肿瘤相比,NF1 PNTs 具有一些特殊性:(1)神经纤维瘤的高患病率;(2)存在特征性肿瘤形式(丛状神经纤维瘤);以及,(3)恶性外周神经鞘瘤(MPNST)的发病率更高(终生风险等于 8-13%)和发病年龄更早(2-3 岁与 3-6 岁)。由于担心引起神经并发症,通常仅建议对有症状的 PNTs 进行手术切除。然而,具有该领域专业知识的外科医生可以安全地进行手术。有效的预防策略也是必不可少的。基于 NF1 中三分之一的 MPNST 是先前存在的良性肿瘤恶性转化的结果,因此应提倡更积极的手术态度。